SCHEMBL24319375

SCHEMBL24319375

CC[C@@H](O)CN1CCNCC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.58
RAD52 P43351 1/20 0.46
SLC18A3 Q16572 1/20 0.45
IDO1 P14902 1/20 0.44
BAX Q07812 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
MAPT P10636 2/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
ALOX15 P16050 1/20 0.42
MAPK1 P28482 1/20 0.42
POLB P06746 1/20 0.42
DRD2 P14416 2/20 0.41
DRD3 P35462 2/20 0.41
ATM Q13315 1/20 0.40
USP2 O75604 1/20 0.40
CHRM5 P08912 1/20 0.39
CHRM3 P20309 1/20 0.39
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17934826 1.00 SMN1; SMN2 (0.58) SMN1; SMN2RAD52SLC18A3IDO1BAX
SCHEMBL2800007 1.00 SMN1; SMN2 (0.58) SMN1; SMN2RAD52SLC18A3IDO1BAX
SCHEMBL9060103 0.88 SMN1; SMN2 (0.46) SMN1; SMN2RAD52SLC18A3IDO1BAX
SCHEMBL11438133 0.86 SMN1; SMN2 (0.60) SMN1; SMN2RAD52IDO1BAXMEN1
SCHEMBL19240286 0.85 RAD52 (0.50) SMN1; SMN2RAD52SLC18A3IDO1BAX
SCHEMBL151400 0.84 SMN1; SMN2 (0.58) SMN1; SMN2RAD52IDO1BAXMEN1
SCHEMBL2801641 0.84 KMT2A (0.52) SMN1; SMN2SLC18A3MEN1KMT2AMAPT
SCHEMBL2801591 0.83 SMN1; SMN2 (0.54) SMN1; SMN2RAD52IDO1BAXMEN1
SCHEMBL570899 0.83 SMN1; SMN2 (0.53) SMN1; SMN2RAD52IDO1BAXMEN1
Hydrochloric Acid SCHEMBL5485556 0.81 SMN1; SMN2 (0.56) SMN1; SMN2RAD52IDO1BAXMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022047145-A1 RAPIDLY ACCELERATING FIBROSARCOMA PROTEIN DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2022-03-03 WO disclosed